Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment Visit
NCT02758145 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 379
Last updated 2018-09-28
Summary
The investigators will compare two groups, an intervention group with a control group. Each employee of the University Hospital of Lausanne (CHUV) and the University Medical Policlinic of Lausanne (PMU) who will do his recruitment visit at the occupational medicine unit of the CHUV between 04/29/16 (end of previous influenza epidemic) and 31/10/16 (the day before the start of the next influenza vaccination campaign) and exert a function in regular contact with patients will be eligible. Depending on his employee number (assigned by the human resources administration, independent of any parameter), he will be placed in the intervention group G1 (odd number) or in the control group G2 (even number). The information concerning the distribution of these two groups will be noted in the computerized medical records of the employee at the occupational medicine unit (Medipho4D software, secured database). Thereafter, the employee will be received by the nurse of the he occupational medicine unit for a recruitment visit according to the usual process. The nurse will perform the study intervention in addition to the usual procedure if it is stipulated ''intervention group'' on the employee's record in the database or only perform the usual steps if it is stipulated ''control group''. At the beginning of the next influenza vaccination campaign (mid-November 2016), employees in the intervention group will receive a letter reminding then about the intervention given during the recruitment visit and inviting them to get vaccinated. During the next influenza vaccination campaign (11.01.16) and until the end of the influenza epidemic that will follow (April 2017), each employee will have the opportunity to be vaccinated at the different vaccination stalls set up by the occupational medicine unit. For each employee vaccinated, the date of vaccination and vaccine name is entered in the electronic medical records of the occupational medicine unit (Medipho4D software) by a nurse or a secretary of the unit. At the end of the human influenza epidemic (April 2017), the data will be extracted from the database (Medipho4D software) and anonymized by an individual not implicated in the study. Data from two groups will be analyzed and compared to assess whether the intervention conducted among newly hired employees promotes influenza vaccination.
Conditions
- Human Influenza Vaccination in Healthcare Workers
Interventions
- OTHER
-
Flu vaccination information in 3 phases
An oral information is given by the nurse during the recruitment visit at the occupational medicine unit. She initiates the discussion on flu and asks the employee if he usually receives the vaccine. Then she provides a brief standardized information on recommendations concerning flu vaccination, and the annual influenza vaccination campaign in CHUV and PMU. She responds to questions. After the interview, she gives an informative document with key messages (information about the disease, benefits to be vaccinated, vaccine safety, etc.). The document includes frequently asked questions, website address, and the email address of the occupational medicine unit in case of questions. The third phase consists of sending to the employee shortly after the start of the next campaign of flu vaccination (November 2016), a postal mail recalling the information provided during the recruitment examination and inviting them to get vaccinated.
Sponsors & Collaborators
-
Service de Médecine Préventive Hospitalière
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2018-04-30
- Completion
- 2018-04-30
More Related Trials
-
Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults
NCT02027233 ·Status: COMPLETED ·Phase: NA
-
Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting
NCT02478905 ·Status: COMPLETED
-
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
NCT01045564 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
NCT00844051 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428 ·Status: COMPLETED ·Phase: PHASE4
-
Childhood Influenza Immunisation in General Practice Invitation Trial
NCT02921633 ·Status: COMPLETED ·Phase: NA
-
Improving Influenza Vaccination Rates in Nurses Through Text Message Reminders : a RCT
NCT02589574 ·Status: UNKNOWN ·Phase: NA
-
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
NCT01022905 ·Status: COMPLETED ·Phase: PHASE4
-
Childhood Influenza Immunisation Invitation Trial in Schools
NCT02883972 ·Status: WITHDRAWN ·Phase: NA
-
Health Management Training to Enhance Influenza Vaccine Immunogenicity
NCT01256515 ·Status: COMPLETED ·Phase: NA
-
Influenza Vaccination of Nursing Home Workers.
NCT00359554 ·Status: TERMINATED ·Phase: NA
-
Influenza Vaccine Uptake Among Healthcare Workers
NCT05521763 ·Status: UNKNOWN ·Phase: NA
-
Influenza Reminder Text-Messaging
NCT06587984 ·Status: COMPLETED ·Phase: NA
-
Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
NCT01764269 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Brief Intervention for Acceptance of Influenza Vaccine in the Primary Care Setting
NCT04568785 ·Status: COMPLETED ·Phase: NA
-
Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
NCT01258062 ·Status: COMPLETED ·Phase: PHASE1
-
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
NCT03331991 ·Status: COMPLETED
-
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
NCT00537524 ·Status: COMPLETED ·Phase: PHASE2
-
Nudge and Motivational Interviewing Interventions to Improve Influenza Vaccine Uptake Among Healthcare Workers in China
NCT07157163 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Improving Influenza Vaccination Rates Among Health Care Professionals
NCT00404664 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00289510 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
NCT00711295 ·Status: COMPLETED ·Phase: PHASE3
-
Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses
NCT00417560 ·Status: WITHDRAWN ·Phase: NA
-
Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician
NCT06123936 ·Status: RECRUITING ·Phase: NA